1. Home
  2. STTK vs RGS Comparison

STTK vs RGS Comparison

Compare STTK & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$3.13

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Logo Regis Corporation

RGS

Regis Corporation

N/A

Current Price

$28.61

Market Cap

71.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
STTK
RGS
Founded
2016
1922
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
71.3M
IPO Year
2020
1991

Fundamental Metrics

Financial Performance
Metric
STTK
RGS
Price
$3.13
$28.61
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
392.9K
6.4K
Earning Date
11-06-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.05
EPS
N/A
45.08
Revenue
$1,000,000.00
$223,032,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.67
Revenue Growth
N/A
13.98
52 Week Low
$0.69
$15.00
52 Week High
$3.38
$31.50

Technical Indicators

Market Signals
Indicator
STTK
RGS
Relative Strength Index (RSI) 67.21 52.19
Support Level $2.82 $28.04
Resistance Level $3.30 $30.17
Average True Range (ATR) 0.25 0.94
MACD -0.01 0.05
Stochastic Oscillator 72.92 56.39

Price Performance

Historical Comparison
STTK
RGS

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

Share on Social Networks: